Amendment: SEC Form SC 13G/A filed by Harrow Inc.

10/8/24 6:41:41 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $HROW alert in real time by email

SC 13G/A 1 harrowhealth13ga.txt SCHEDULE 13 G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) Harrow Health, Inc. (Name of Issuer) Ordinary Shares (Title of Class of Securities) 415858109 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ? CUSIP No. 415858109 13G Page 2 of 8 Pages 1. NAMES OF REPORTING PERSONS OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Ophir Global Opportunities Fund 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Australia NUMBER OF SHARES BENEFICIALLY OWNED EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 768,916 Ordinary Shares 6. SHARED VOTING POWER 7. SOLE DISPOSITIVE POWER 768,916 Ordinary Shares 8. SHARED DISPOSITIVE POWER 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 768,916 Ordinary Shares 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.80% 12. TYPE OF REPORTING PERSON (see instructions) OO ? CUSIP No. 415858109 13G Page 3 of 8 Pages Item 1. (a) Name of Issuer Harrow Health, Inc. (b) Address of Issuer?s Principal Executive Offices 102 Woodmont Blvd., Suite 610 Nashville, Tennessee 37205 Item 2. (a) Name of Person Filing Ophir Global Opportunities Fund (b) The address of the principal place of the Filers is located at: Level 27, Governor Philip Tower One Farrer Place, Sydney, NSW 2000 (c) For citizenship of Filers, see Item 4 of the cover sheet for each Filer. Ophir Funds are Australian-domiciled. (d) Title of Class of Securities Ordinary Shares (e) CUSIP Number 415858109 Item 3. If this statement is filed pursuant to ??240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [X] An investment adviser in accordance with ?240.13d- 1(b)(1)(ii)(E); CUSIP No. 415858109 13G Page 4 of 8 Pages (g) [ ] A parent holding company or control person in accordance with ?240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with ?240.13d-1(b)(1)(ii)(J). ? CUSIP No. 415858109 13G Page 5 of 8 Pages Item 4. Ownership. (a) Amount beneficially owned: 768,916 Ordinary Shares* (b) Percent of class: 2.8% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 768,916 Ordinary Shares* (ii) Shared power to vote or to direct the vote (iii) Sole power to dispose or to direct the disposition of 768,916 Ordinary Shares* (iv) Shared power to dispose or to direct the disposition of * Ophir Asset Management US LLC serves as the investment manager to Ophir Global Opportunities Fund, Ophir Global High Conviction Fund, collectively the ?Ophir Funds? and the Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the Shares for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of the Reporting Person?s pecuniary interest therein. The percentages herein are calculated based upon a statement in the Issuer?s Form 10-Q, as of September 30, 2022 which was filed on November 14, 2022, that there were 27,413,654 shares of common stock issued and outstanding. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X] CUSIP No. 415858109 13G Page 6 of 8 Pages Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. ? CUSIP No. 415858109 13G Page 7 of 8 Pages Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 07, 2022 Ophir Asset Management US LLC By: /s/ Melanie Harris, CCO ________________________________________ ? CUSIP No. 415858109 13G Page 8 of 8 Pages EXHIBIT A AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G Statement Pursuant to Rule 13d-1(k)(1) The undersigned hereby consent and agree to file a joint statement on Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock of Harrow Health, Inc. beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent this Statement pursuant to Rule 13d- 1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule 13G. Dated: February 07, 2023 Ophir Asset Management US LLC By: /s/ Melanie Harris, CCO ________________________________________

Get the next $HROW alert in real time by email

Recent Analyst Ratings for

$HROW

Date	Price Target	Rating	Analyst
7/11/2025	$76.00	Overweight	Cantor Fitzgerald
6/12/2025	$62.00	Buy	BTIG Research
6/10/2025		Outperform	William Blair
2/6/2025	$57.00	Buy	H.C. Wainwright
12/4/2024	$73.00 → $69.00	Buy	B. Riley Securities
4/11/2024	$24.00	Buy	Craig Hallum
9/8/2022	$17.00	Buy	B. Riley Securities
10/14/2021	$16.00	Buy	B. Riley Securities

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Harrow Inc.

10/8/24 6:41:41 AM ET

$HROW

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $HROW alert in real time by email

Recent Analyst Ratings for

$HROW

Date	Price Target	Rating	Analyst
7/11/2025	$76.00	Overweight	Cantor Fitzgerald
6/12/2025	$62.00	Buy	BTIG Research
6/10/2025		Outperform	William Blair
2/6/2025	$57.00	Buy	H.C. Wainwright
12/4/2024	$73.00 → $69.00	Buy	B. Riley Securities
4/11/2024	$24.00	Buy	Craig Hallum
9/8/2022	$17.00	Buy	B. Riley Securities
10/14/2021	$16.00	Buy	B. Riley Securities

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Harrow Inc.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$HROW

Amendment: SEC Form SC 13G/A filed by Harrow Inc.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$HROW

$HROW
Insider Purchases

Opaleye Management Inc. bought $199,400 worth of shares (20,000 units at $9.97) (SEC Form 4)

Opaleye Management Inc. bought $204,640 worth of shares (20,000 units at $10.23) (SEC Form 4)

Opaleye Management Inc. bought $310,390 worth of shares (29,400 units at $10.56) (SEC Form 4)

$HROW
Insider Trading

SEC Form 4 filed by CHIEF ACCOUNTING OFFICER Pollard Randall E.

SEC Form 3 filed by new insider Pollard Randall E.

CHIEF EXECUTIVE OFFICER Baum Mark L covered exercise/tax liability with 313,338 shares and exercised 600,000 shares at a strike of $7.87, increasing direct ownership by 11% to 2,886,124 units (SEC Form 4)

$HROW
SEC Filings

Amendment: Harrow Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

Harrow Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

Harrow Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

$HROW
Press Releases

Harrow to Acquire Melt Pharmaceuticals

Harrow Launches Harrow Access for All (HAFA)

Harrow Announces Agenda and Speakers for Investor & Analyst Day

$HROW
Analyst Ratings

Cantor Fitzgerald initiated coverage on Harrow with a new price target

BTIG Research initiated coverage on Harrow with a new price target

William Blair initiated coverage on Harrow

$HROW
Leadership Updates

Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications

Harrow Appoints Amir H. Shojaei as Chief Scientific Officer

Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial

$HROW
Large Ownership Changes

$HROW
Financials